Groundbreaking Clinical Results

Pioneering tension-offloading technology for superior scar remodeling.
Backed by 510(k) clearance and over a decade of rigorous clinical research
and publication in major medical journals.

 FDA CLEARED
Shop embrace®
✔ PEER REVIEWED
Our Multi-Modal Evaluation
To provide unequivocal clinical evidence, our methodology utilizes two industry-leading diagnostic pillars to quantify tissue remodeling and fat distribution changes.
 
20%
Volume Reduction Ultrasound Analysis
The gold standard for subcutaneous volume measurement, providing high-resolution visualization of lesion reduction.
embrace Treated
Baseline
6.97x
Fat Reduction
Biopsy Sampling
Cellular-level evaluation of lipid accumulation to quantify adipocyte remodeling.
 
embrace Treated
Baseline
1.52x
Scar Remodeling
Biopsy Sampling
Quantifying the remodeling of fibrotic tissue into healthy skin.
embrace Treated
Baseline

 

Real Feedback From The Patients In Our Clinical Trial

 

 

 

63%

Reported regaining a site.

A comprehensive 16-week study focusing on the long-term efficacy of mechanomodulation in patients with Type 1 diabetes.
Statistical Significance
High (p<0.01)
Duration
16 weeks
0

Adverse events across 200+ patient days.

48%

Reported improved insulin absorption

>70%

Reported embrace was comfortable, discreet, convenient and easy to apply

56%

Anticipate wearing embrace daily for prevention of LH

Presented at the American Diabetes Association (ADA) 84th Scientific Sessions 2025 & European Association for the Study of Diabetes (EASD)
Read the study here

Peer-Reviewed Studies

Plastic and Reconstructive Surgery
Randomized Controlled Trial of the embrace Advanced Scar Therapy
Device to Reduce Incisional Scar Formation
Plastic and Reconstructive Surgery
The embrace Device Significantly Decreases Scarring
following Scar Revision Surgery in a Randomized Controlled Trial

Protect Your Sites With embrace